[1] EMBERSON J, LEES KR, LYDEN P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials[J]. Lancet, 2014, 384(9958): 1929. doi: 10.1016/S0140-6736(14)60584-5
[2] HUSSAIN MS, LIN R, MOSKOWITZ S, et al. Symptomatic delayed reocclusion after initial successful revascularization in acute ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2010, 19(1): 36. doi: 10.1016/j.jstrokecerebrovasdis.2009.03.002
[3] GELDERBLOM M, LEYPOLDT F, STEINBACH K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke[J]. Stroke, 2009, 40(5): 1849. doi: 10.1161/STROKEAHA.108.534503
[4] CHEN GY, NUÑEZ G. Sterile inflammation: sensing and reacting to damage[J]. Nat Rev Immunol, 2010, 10(12): 826. doi: 10.1038/nri2873
[5] TOKGOZ S, KESKIN S, KAYRAK M, et al. Is neutrophil/lymphocyte ratio predict to short-term mortality in acute cerebral infarct independently from infarct volume[J]. J Stroke Cerebrovasc Dis, 2014, 23(8): 2163. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.007
[6] NEUMANN J, RIEK-BURCHARDT M, HERZ J, et al. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke[J]. Acta Neuropathol, 2015, 129(2): 259. doi: 10.1007/s00401-014-1355-2
[7] PEREZ-DE-PUIG I, MIRÓ-MUR F, FERRER-FERRER M, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke[J]. Acta Neuropathol, 2015, 129(2): 39.
[8] NEUMANN J, SAUERZWEIG S, RÖNICKE R, et al. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege[J]. J Neurosci, 2008, 28(23): 5965. doi: 10.1523/JNEUROSCI.0060-08.2008
[9] JUSTICIA C, PANÉS J, SOLÉ S, et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats[J]. J Cereb Blood Flow Metab, 2003, 23(12): 1430. doi: 10.1097/01.WCB.0000090680.07515.C8
[10] RØRVIG S, HONORE C, LARSSON LI, et al. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP[J]. J Leukoc Biol, 2009, 86(6): 1439. doi: 10.1189/jlb.1008606
[11] JICKLING GC, LIU D, STAMOVA B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans[J]. J Cereb Blood Flow Metab, 2014, 34(2): 185. doi: 10.1038/jcbfm.2013.203
[12] ROSELL A, CUADRADO E, ORTEGA-AZNAR A, et al. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type Ⅳ collagen degradation during hemorrhagic transformation after human ischemic stroke[J]. Stroke, 2008, 39(4): 1121. doi: 10.1161/STROKEAHA.107.500868
[13] BODHANKAR S, CHEN Y, VANDENBARK AA, et al. IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke[J]. Metab Brain Dis, 2013, 28(3): 375. doi: 10.1007/s11011-013-9413-3
[14] O'GARRA A, VIEIRA P. Regulatory T cells and mechanisms of immune system control[J]. Nat Med, 2004, 10(8): 801. doi: 10.1038/nm0804-801
[15] SONG Q, LI Y, WANG Y, et al. Increased neutrophil-to-lymphocyte ratios are associated with greater risk of hemorrhagic transformation in patients with acute ischemic stroke[J]. Curr Neurovasc Res, 2018, 15(4): 326.
[16] DUAN Z, WANG H, WANG Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke[J]. Cerebrovasc Dis, 2018, 45(5): 221.
[17] PÉTRAULT O, OUK T, GAUTIER S, et al. Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion[J]. Br J Pharmacol, 2005, 144(8): 1051. doi: 10.1038/sj.bjp.0706124
[18] CONNOLLY ES JR, WINFREE CJ, SPRINGER TA, et al. Cerebral protection in homozygous null ICAM-01 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke[J]. J Clin Invest, 1996, 97(1): 209. doi: 10.1172/JCI118392
[19] YENARI MA, KUNIS D, SUN GH, et al. Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia[J]. Exp Neurol, 1998, 153(2): 223. doi: 10.1006/exnr.1998.6876
[20] LI P, MAO L, LIU X, et al. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke[J]. Stroke, 2014, 45(3): 857. doi: 10.1161/STROKEAHA.113.004100